Effects of interferon-gamma on bleomycin-induced pulmonary fibrosis in rats at the fibrosing stage
Deping Zhang
Abstract
Deping Zhang
Abstract
Objective: To observe the change of the levels of tumor necrosis factor-α(TNF-α),interferon-γ(IFN-γ) and interleukin-10(IL-10) in bronchial alveolar lavage fluid(BALF) from rats with pulmonary fibrosis induced by bleomycin and investigate the intervention by IFN-γ on it. Methods: The SD rats were randomly divided into three groups: the normal control group(Group N),the bleomycin-A_5 group(Group B),and the interferon-γ treated group(Group I).The pulmonary fibrosis model was established by a single intratracheal injection of 5 mg/kg of bleomycin.The rats were sacrificed at day 17,21,28 after modeling in batch.Semi-quantitative analysis of the histopathologic changes stained with Haematoxylin-eosin(H-E) was performed.The levels of TNF-α,IFN-γ and IL-10 in BALF were measured with ELISA.The content of hydroxyproline in the lungs was determined by digestion method.Results:①The scores of pulmonary alveolitis and pulmonary fibrosis in Group I and Group B were significantly higher from 17d after bleomycin administration compared with Group N(all P0.01).②In Group I,the level of TNF-α protein in BALF was significantly increased from 17d after modeling compared with Group N and Group B(all P0.01).The significantly increased level of IFNγ protein in BALF after IFN-γ administration was seen at 21 d and 28 d compared with Group N and Group B(P(0.05)).The level of IL-10 protein in BALF in Group I was significantly increased at 17 d in comparison with the normal group(P0.01).③The contents of hydroxyproline in the lungs in Group I and Group B were significantly higher from 17 d after bleomycin administration compared with Group N(all P(0.01)). Conclusion: The treatment of IFN-γ does not significantly influence progression of pulmonary fibrosis at the fibrosing stage by enhancing the levels of TNF-α,IFN-γ and IL-10 protein in vivo.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective: To observe the change of the levels of tumor necrosis factor-α(TNF-α),interferon-γ(IFN-γ) and interleukin-10(IL-10) in bronchial alveolar lavage fluid(BALF) from rats with pulmonary fibrosis induced by bleomycin and investigate the intervention by IFN-γ on it. Methods: The SD rats were randomly divided into three groups: the normal control group(Group N),the bleomycin-A_5 group(Group B),and the interferon-γ treated group(Group I).The pulmonary fibrosis model was established by a single intratracheal injection of 5 mg/kg of bleomycin.The rats were sacrificed at day 17,21,28 after modeling in batch.Semi-quantitative analysis of the histopathologic changes stained with Haematoxylin-eosin(H-E) was performed.The levels of TNF-α,IFN-γ and IL-10 in BALF were measured with ELISA.The content of hydroxyproline in the lungs was determined by digestion method.Results:①The scores of pulmonary alveolitis and pulmonary fibrosis in Group I and Group B were significantly higher from 17d after bleomycin administration compared with Group N(all P0.01).②In Group I,the level of TNF-α protein in BALF was significantly increased from 17d after modeling compared with Group N and Group B(all P0.01).The significantly increased level of IFNγ protein in BALF after IFN-γ administration was seen at 21 d and 28 d compared with Group N and Group B(P(0.05)).The level of IL-10 protein in BALF in Group I was significantly increased at 17 d in comparison with the normal group(P0.01).③The contents of hydroxyproline in the lungs in Group I and Group B were significantly higher from 17 d after bleomycin administration compared with Group N(all P(0.01)). Conclusion: The treatment of IFN-γ does not significantly influence progression of pulmonary fibrosis at the fibrosing stage by enhancing the levels of TNF-α,IFN-γ and IL-10 protein in vivo.
Key concepts: Bleomycin, Pulmonary fibrosis, Medicine, Hydroxyproline, Tumor necrosis factor alpha, Fibrosis, Lung, Pathology